李雨庭（民102）。臺北市社區獨居老人健康狀況、健康促進生活型態與幸福感之研究（碩士論文）。取自台灣碩博士論文系統。
花茂棽、張本聖、林克能、楊建銘、盧小蓉、陳心怡 (民94)。魏氏記憶力量表第三版 (WMS-III) 中文版指導手冊。台北市︰中國行為科學社。
高至潔（民98）。台灣版正常中老年人尼爾森修訂版卡片分類測驗之常模研究（碩士論文）。取自台灣碩博士論文系統。
郭曉燕、花茂棽（民104）。彩色路徑描繪測驗（中文版）指導手冊。台北：中國行為科學社。
陳佳微（民102）。比較中文版之RUDAS、MMSE及MoCA於篩檢輕度認知障礙或失智症患者之敏感性、特異性分析（碩士論文）。取自台灣碩博士論文系統。
陳勁秀（民99）。台灣正常中老年人語意流暢度測驗之北部地區常模研究（碩士論文）。取自台灣碩博士論文系統。
陳榮華、陳心怡（民91）。魏氏成人至力量表第三版（中文版）指導手冊。台北：中國行為科學社。
蘇芳緹（民108）。巴金森氏病患者之社會功能量表編製研究（碩士論文）。取自台灣碩博士論文系統。
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021, 2021/07/01). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 47. https://doi.org/10.1038/s41572-021-00280-3
Aarsland, D., Brønnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007). Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery & Psychiatry, 78(1), 36-42.
Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., Santangelo, G., Foltynie, T., Janvin, C., Larsen, J. P., Barker, R. A., & Emre, M. (2010). Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology, 75(12), 1062-1069. https://doi.org/10.1212/wnl.0b013e3181f39d0e
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., Weintraub, D., & Ballard, C. (2017). Cognitive decline in Parkinson disease. Nature Reviews Neurology, 13(4), 217-231.
Aarsland, D., & Kurz, M. W. (2010). The Epidemiology of Dementia Associated with Parkinson's Disease. Brain Pathology, 20(3), 633-639. https://doi.org/10.1111/j.1750-3639.2009.00369.x
Abbas, M. M., Xu, Z., & Tan, L. C. S. (2018). Epidemiology of Parkinson's Disease-East Versus West. Movement Disorders Clinical Practice, 5(1), 14-28. https://doi.org/10.1002/mdc3.12568
Alexandra, P. P. (2015). Assessment of MoCA, Rey, Trails A tests for the characterization of MCI in PD screening using covariate information
Anderson, R. J., Simpson, A. C., Channon, S., Samuel, M., & Brown, R. G. (2013). Social problem solving, social cognition, and mild cognitive impairment in Parkinson's disease. Behavioral neuroscience, 127(2), 184.
Armstrong, M. J., & Okun, M. S. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 323(6), 548-560. https://doi.org/10.1001/jama.2019.22360
Auditory, S. (1996). Auditory and verbal learning test: A handbook. Western Psychological Services: Los Angeles, CA, USA.
Badrkhahan, S. Z., Sikaroodi, H., Sharifi, F., Kouti, L., & Noroozian, M. (2019). Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson’s disease. Applied Neuropsychology: Adult.
Becker, S., Bäumer, A., Maetzler, W., Nussbaum, S., Timmers, M., Van Nueten, L., Salvadore, G., Zaunbrecher, D., Roeben, B., Brockmann, K., Streffer, J., Berg, D., & Liepelt-Scarfone, I. (2020). Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients. Journal of neuropsychology, 14(1), 69-84. https://doi.org/https://doi.org/10.1111/jnp.12173
Bennett, D. A., Schneider, J. A., Tang, Y., Arnold, S. E., & Wilson, R. S. (2006, May). The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol, 5(5), 406-412. https://doi.org/10.1016/s1474-4422(06)70417-3
Benton, A., Hamsher, K. d., & Sivan, A. (1989). Multilingual Aphasia Examination. Iowa City, IA: AJA Associates. NEUROPSYCHOLOGY, BLOCKING, SCHIZOPHRENIA, 59.
Benton, A. L., Eslinger, P. J., & Damasio, A. R. (1981). Normative observations on neuropsychological test performances in old age. Journal of Clinical and Experimental Neuropsychology, 3(1), 33-42.
Besser, L. M., Litvan, I., Monsell, S. E., Mock, C., Weintraub, S., Zhou, X.-H., & Kukull, W. (2016, 2016/06/01/). Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. Parkinsonism & Related Disorders, 27, 54-60. https://doi.org/https://doi.org/10.1016/j.parkreldis.2016.04.007
Bezdicek, O., Červenková, M., Moore, T. M., Stepankova Georgi, H., Sulc, Z., Wolk, D. A., Weintraub, D. A., Moberg, P. J., Jech, R., Kopecek, M., & Roalf, D. R. (2020, Dec). Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison. Assessment, 27(8), 1960-1970. https://doi.org/10.1177/1073191118778896
Bezdicek, O., Moták, L., Schretlen, D. J., Preiss, M., Axelrod, B., Nikolai, T., & Růžička, E. (2016). Sociocultural and language differences on the Trail Making Test. Archives of Assessment Psychology, 6(1), 33-48.
Biundo, R., Weis, L., Facchini, S., Formento-Dojot, P., Vallelunga, A., Pilleri, M., & Antonini, A. (2014, 2014/04/01/). Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism & Related Disorders, 20(4), 394-399. https://doi.org/https://doi.org/10.1016/j.parkreldis.2014.01.009
Bocti C, C. P., Fulop T, Lacombe G, Létourneau C. . (2012). Designing an abridged Montreal Cognitive Assessment for more efficient cognitive screening. Alzheimers Dement.
Bocti, C., Legault, V., Leblanc, N., Berger, L., Nasreddine, Z., Beaulieu-Boire, I., Yaneva, K., & Boulanger, J.-M. (2013). Vascular Cognitive Impairment: Most Useful Subtests of the Montreal Cognitive Assessment in Minor Stroke and Transient Ischemic Attack. Dementia and Geriatric Cognitive Disorders, 36(3-4), 154-162. https://doi.org/10.1159/000351674
Boller, F. O., Mizutani, T., Roessmann, U., & Gambetti, P. (1980). Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations. Annals of Neurology, 7(4), 329-335. https://doi.org/10.1002/ana.410070408
Borod, J. C., Goodglass, H., & Kaplan, E. (1980). Normative data on the Boston diagnostic aphasia examination, parietal lobe battery, and the Boston naming test. Journal of Clinical and Experimental Neuropsychology, 2(3), 209-215.
Borson, S., Scanlan, J., Brush, M., Vitaliano, P., & Dokmak, A. (2000). The Mini-Cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. International Journal of Geriatric Psychiatry, 15(11), 1021-1027. https://doi.org/https://doi.org/10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6
Bothe, M. R., Uttner, I., & Otto, M. (2010). Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. Journal of Neural Transmission, 117(3), 353-367.
Brandstaedter, D., Spieker, S., Ulm, G., Siebert, U., Eichhorn, T., Krieg, J., Oertel, W., & Eggert, K. (2005). Development and evaluation of the Parkinson Psychosis Questionnaire. Journal of Neurology, 252(9), 1060-1066.
Buschke, H., Kuslansky, G., Katz, M., Stewart, W. F., Sliwinski, M. J., Eckholdt, H. M., & Lipton, R. B. (1999). Screening for dementia with the Memory Impairment Screen. Neurology, 52(2), 231-231. https://doi.org/10.1212/wnl.52.2.231
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008). Dementia and survival in Parkinson disease. A 12-year population study, 70(13), 1017-1022. https://doi.org/10.1212/01.wnl.0000306632.43729.24
Cameron, J. D., Gallagher, R., Pressler, S. J., McLennan, S. N., Ski, C. F., Tofler, G., & Thompson, D. R. (2016, Feb). Sensitivity and Specificity of a Five-Minute Cognitive Screening Test in Patients With Heart Failure. J Card Fail, 22(2), 99-107. https://doi.org/10.1016/j.cardfail.2015.08.343
Campbell, N., Rice, D., Friedman, L., Speechley, M., & Teasell, R. W. (2016). Screening and facilitating further assessment for cognitive impairment after stroke: application of a shortened Montreal Cognitive Assessment (miniMoCA). Disability and Rehabilitation, 38(6), 601-604. https://doi.org/10.3109/09638288.2015.1047968
Cecato, J. F., Martinelli, J. E., Izbicki, R., Yassuda, M. S., & Aprahamian, I. (2016, May). A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease? Int Psychogeriatr, 28(5), 825-832. https://doi.org/10.1017/S1041610215001982
Chen, L., Yu, C., Fu, X., Liu, W., Hua, P., Zhang, N., & Kuo, S. (2013). Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease. Shanghai archives of psychiatry, 25(5), 296-305. https://doi.org/10.3969/j.issn.1002-0829.2013.05.005
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., De Silva, R., Lees, A. J., & Revesz, T. (2011). Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain, 134(5), 1493-1505. https://doi.org/10.1093/brain/awr031
Cooper, J. A., Sagar, H. J., Jordan, N., Harvey, N. S., & Sullivan, E. V. (1991). Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain, 114(5), 2095-2122.
Cooper, J. A., Sagar, H. J., & Sullivan, E. V. (1993). Short-term memory and temporal ordering in early Parkinson's disease: Effects of disease chronicity and medication. Neuropsychologia, 31(9), 933-949. https://doi.org/10.1016/0028-3932(93)90149-t
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308-2308.
Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J., Keenan, R., Wells, S., Porter, R. J., Watts, R., & Anderson, T. J. (2010, Nov 9). The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology, 75(19), 1717-1725. https://doi.org/10.1212/WNL.0b013e3181fc29c9
Dickson, D. W. (2012). Parkinson’s disease and parkinsonism: neuropathology. Cold Spring Harbor perspectives in medicine, 2(8), a009258.
Dong, Y., Koay, W. I., Yeo, L. L. L., Chen, C. L.-H., Xu, J., Seet, R. C. S., & Lim, E. C. H. (2015). Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study. Parkinson's Disease, 2015, 1-6. https://doi.org/10.1155/2015/348063
Dormann, C. F., Elith, J., Bacher, S., Buchmann, C., Carl, G., Carré, G., Marquéz, J. R. G., Gruber, B., Lafourcade, B., Leitão, P. J., Münkemüller, T., McClean, C., Osborne, P. E., Reineking, B., Schröder, B., Skidmore, A. K., Zurell, D., & Lautenbach, S. (2013). Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography, 36(1), 27-46. https://doi.org/10.1111/j.1600-0587.2012.07348.x
Downes, J. J., Sharp, H. M., Costall, B. M., Sagar, H. J., & Howe, J. (1993). Alternating fluency in Parkinson's disease. Brain, 116(4), 887-902. https://doi.org/10.1093/brain/116.4.887
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., Korczyn, A., Lees, A., Levy, R., Litvan, I., Mizuno, Y., McKeith, I. G., Olanow, C. W., Poewe, W., Sampaio, C., Tolosa, E., & Emre, M. (2007, Dec). Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord, 22(16), 2314-2324. https://doi.org/10.1002/mds.21844
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2002). Risk tables for parkinsonism and Parkinson's disease. Journal of Clinical Epidemiology, 55(1), 25-31.
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22(12), 1689-1707. https://doi.org/https://doi.org/10.1002/mds.21507
Ertan, F., Ertan, T., Kızıltan, G., & Uygucgil, H. (2005). Reliability and validity of the Geriatric Depression Scale in depression in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 76(10), 1445-1447.
Fankhauser, S., Forstmeier, S., Maercker, A., Luppa, M., Luck, T., & Riedel-Heller, S. G. (2015). Risk of Dementia in Older Adults With Low Versus High Occupation-Based Motivational Processes:Differential Impact of Frequency and Proximity of Social Network. Journal of Geriatric Psychiatry and Neurology, 28(2), 126-135. https://doi.org/10.1177/0891988714554706
Federico, A., Maier, A., Vianello, G., Mapelli, D., Trentin, M., Zanette, G., Picelli, A., Gandolfi, M., & Tamburin, S. (2015). Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests. Parkinson's Disease, 2015, 1-10. https://doi.org/10.1155/2015/681976
Fengler, S. (2016). Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting. PLoS One.
Fernández, A. L., & Marcopulos, B. A. (2008). A comparison of normative data for the Trail Making Test from several countries: Equivalence of norms and considerations for interpretation. Scandinavian Journal of Psychology, 49(3), 239-246. https://doi.org/10.1111/j.1467-9450.2008.00637.x
Flowers, K., & Robertson, C. (1985). The effect of Parkinson's disease on the ability to maintain a mental set. Journal of Neurology, Neurosurgery & Psychiatry, 48(6), 517-529.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.
Freitas, S., Batista, S., Afonso, A. C., Simões, M. R., De Sousa, L., Cunha, L., & Santana, I. (2018). The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis. Applied Neuropsychology: Adult, 25(1), 57-70. https://doi.org/10.1080/23279095.2016.1243108
Galvin, J. E., Pollack, J., & Morris, J. C. (2006). Clinical phenotype of Parkinson disease dementia. Neurology, 67(9), 1605-1611. https://doi.org/10.1212/01.wnl.0000242630.52203.8f
Goetz, C. G., Emre, M., & Dubois, B. (2008). Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 64(S2), S81-S92.
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., & Wenning, G. K. (2004). Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson's disease. Movement Disorders, 19(9), 1020-1028.
Goldman, J. G., Holden, S., Bernard, B., Ouyang, B., Goetz, C. G., & Stebbins, G. T. (2013). Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Movement Disorders, 28(14), 1972-1979. https://doi.org/https://doi.org/10.1002/mds.25655
Goldman, J. G., & Sieg, E. (2020). Cognitive impairment and dementia in Parkinson disease. Clinics in Geriatric Medicine, 36(2), 365-377.
Grober, E., & Buschke, H. (1987). Genuine memory deficits in dementia. Developmental neuropsychology, 3(1), 13-36.
Hanagasi, H. A., Tufekcioglu, Z., & Emre, M. (2017, 2017/03/15/). Dementia in Parkinson's disease. Journal of the Neurological Sciences, 374, 26-31. https://doi.org/https://doi.org/10.1016/j.jns.2017.01.012
Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29-36. https://doi.org/10.1148/radiology.143.1.7063747
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008). The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Movement Disorders, 23(6), 837-844. https://doi.org/https://doi.org/10.1002/mds.21956
Hobson, P., & Meara, J. (2004). Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Movement Disorders, 19(9), 1043-1049. https://doi.org/10.1002/mds.20216
Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73(21), 1738-1745. https://doi.org/10.1212/WNL.0b013e3181c34b47
Horton, D. K., Hynan, L. S., Lacritz, L. H., Rossetti, H. C., Weiner, M. F., & Cullum, C. M. (2015). An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening. The Clinical Neuropsychologist, 29(4), 413-425. https://doi.org/10.1080/13854046.2015.1043349
Hua, M. S., Chang, S. H., & Chen, S. T. (1997). Factor structure and age effects with an aphasia test battery in normal Taiwanese adults. Neuropsychology, 11(1), 156.
Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. Y., Leverenz, J. B., Montine, T. J., Duda, J. E., Hurtig, H. I., & Trojanowski, J. Q. (2012). Neuropathologic substrates of Parkinson disease dementia. Annals of Neurology, 72(4), 587-598. https://doi.org/10.1002/ana.23659
Janvin, C., Aarsland, D., Larsen, J. P., & Hugdahl, K. (2003). Neuropsychological profile of patients with Parkinson’s disease without dementia. Dementia and Geriatric Cognitive Disorders, 15(3), 126-131.
Jellinger, K. A., Seppi, K., Wenning, G. K., & Poewe, W. (2002, 2002/03//). Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 109(3), 329-339. https://doi.org/10.1007/s007020200027
Jones, R. N., & Gallo, J. J. (2000). Dimensions of the Mini-Mental State Examination among community dwelling older adults. Psychological Medicine, 30(3), 605-618. https://doi.org/10.1017/s0033291799001853
Kalia, L. V., Lang, A. E., Hazrati, L. N., Fujioka, S., Wszolek, Z. K., Dickson, D. W., Ross, O. A., Van Deerlin, V. M., Trojanowski, J. Q., & Hurtig, H. I. (2015). Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurology, 72(1), 100-105.
Kandiah, N., Zhang, A., Cenina, A. R., Au, W. L., Nadkarni, N., & Tan, L. C. (2014). Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease. Parkinsonism & Related Disorders, 20(11), 1145-1148.
Kane, R. A. (1987). Assessing Social Function in the Elderly. Clinics in Geriatric Medicine, 3(1), 87-98. https://doi.org/https://doi.org/10.1016/S0749-0690(18)30828-0
Kaplan, E., & Goodglass, H. (1983). Weintraub. Boston Naming Test. Philadelphia: Lea & Febiger.
Katz, S. (1983). Assessing self‐maintenance: activities of daily living, mobility, and instrumental activities of daily living. Journal of the American Geriatrics Society, 31(12), 721-727.
Kaur, A., Edland, S., & Peavy, G. (2018, 01/09). The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders, 32, 1. https://doi.org/10.1097/WAD.0000000000000240
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. The Lancet Neurology, 9(12), 1200-1213. https://doi.org/10.1016/s1474-4422(10)70212-x
Larner, A. J. (2017). Short Montreal Cognitive Assessment:Validation and Reproducibility. Journal of Geriatric Psychiatry and Neurology, 30(2), 104-108. https://doi.org/10.1177/0891988716673469
Leentjens, A. F., Verhey, F. R., Lousberg, R., Spitsbergen, H., & Wilmink, F. W. (2000). The validity of the Hamilton and Montgomery‐Åsberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. International Journal of Geriatric Psychiatry, 15(7), 644-649.
Lees, A., & Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106(2), 257-270.
Levy, G., Jacobs, D. M., Tang, M.-X., Côté, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002). Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders, 17(6), 1221-1226. https://doi.org/10.1002/mds.10280
Lhermitte, F., Pillon, B., & Serdaru, M. (1986). Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 19(4), 326-334.
Lim, J. S., Oh, M. S., Lee, J. H., Jung, S., Kim, C., Jang, M. U., Lee, S. H., Kim, Y. J., Kim, Y., Park, J., Kang, Y., Yu, K.-H., & Lee, B.-C. (2017, May 2017). Prediction of post-stroke dementia using NINDS-CSN 5-minute neuropsychology protocol in acute stroke. International Psychogeriatrics, 29(5), 777-784. https://doi.org/http://dx.doi.org/10.1017/S1041610216002520
Lin, H. F., Chern, C. M., Chen, H. M., Yeh, Y. C., Yao, S. C., Huang, M. F., Wang, S. J., Chen, C.-S., & Fuh, J.-L. (2016). Validation of NINDS-VCI Neuropsychology Protocols for Vascular Cognitive Impairment in Taiwan. PLoS One, 11(6), e0156404. https://doi.org/10.1371/journal.pone.0156404
Lin, K. N., Wang, P. N., Chen, C., Chiu, Y. H., Kuo, C. C., Chuang, Y. Y., & Liu, H. C. (2003). The Three-Item Clock-Drawing Test: A Simplified Screening Test for Alzheimer’s Disease. European Neurology, 49(1), 53-58. https://doi.org/10.1159/000067026
Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodriguez-Oroz, M. C., Tröster, A. I., & Weintraub, D. (2011). MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Movement Disorders, 26(10), 1814-1824. https://doi.org/10.1002/mds.23823
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012, 2012/03/01). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines [https://doi.org/10.1002/mds.24893]. Movement Disorders, 27(3), 349-356. https://doi.org/https://doi.org/10.1002/mds.24893
Liu, W. M., Wu, R. M., Lin, J. W., Liu, Y. C., Chang, C. H., & Lin, C. H. (2016). Time trends in the prevalence and incidence of Parkinson's disease in Taiwan: A nationwide, population-based study. Journal of the Formosan Medical Association, 115(7), 531-538.
Lolekha, P., Tangkanakul, C., Saengchatri, T., & Kulkeartprasert, P. (2021). The Six‐item Clock‐Drawing Scoring System: a rapid screening for cognitive impairment in Parkinson's disease. Psychogeriatrics, 21(1), 24-31. https://doi.org/10.1111/psyg.12605
Lusted, L. B. (1971). Decision-Making Studies in Patient Management. New England Journal of Medicine, 284(8), 416-424. https://doi.org/10.1056/nejm197102252840805
Mahieux, F., Michelet, D., Manifacier, M.-J., Boller, F., Fermanian, J., & Guillard, A. (1995). Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behavioural neurology, 8(1), 15-22.
Mai, L. M., Oczkowski, W., Mackenzie, G., Shuster, A., Wasielesky, L., Franchetto, A., Patlas, M., & Sahlas, D. J. (2013). Screening for Cognitive Impairment in a Stroke Prevention Clinic Using the MoCA. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 40(2), 192-197. https://doi.org/10.1017/S031716710001372X
Marras, C., Armstrong, M. J., Meaney, C. A., Fox, S., Rothberg, B., Reginold, W., Tang-Wai, D. F., Gill, D., Eslinger, P. J., Zadikoff, C., Kennedy, N., Marshall, F. J., Mapstone, M., Chou, K. L., Persad, C., Litvan, I., Mast, B. T., Gerstenecker, A. T., Weintraub, S., & Duff-Canning, S. (2013). Measuring mild cognitive impairment in patients with Parkinson's disease. Movement Disorders, 28(5), 626-633. https://doi.org/10.1002/mds.25426
Marras, C., McDermott, M. P., Rochon, P. A., Tanner, C. M., Naglie, G., & Lang, A. E. (2008). Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial. Movement Disorders, 23(5), 653-659. https://doi.org/10.1002/mds.21853
Martin, R. C., Okonkwo, O. C., Hill, J., Griffith, H. R., Triebel, K., Bartolucci, A., Nicholas, A. P., Watts, R. L., Stover, N., Harrell, L. E., Clark, D., & Marson, D. C. (2008). Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia. Movement Disorders, 23(13), 1867-1874. https://doi.org/10.1002/mds.22170
Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620. https://doi.org/10.1212/01.wnl.0000434309.85312.19
Matison, R., Mayeux, R., Rosen, J., & Fahn, S. (1982). “Tip‐of‐the‐tongue” phenomenon in Parkinson disease. Neurology, 32(5), 567-567.
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000, 2000/07/01). Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathologica, 100(3), 285-290. https://doi.org/10.1007/s004019900168
Mavandadi, S., Nazem, S., Ten Have, T. R., Siderowf, A. D., Duda, J. E., Stern, M. B., & Weintraub, D. (2009). Use of Latent Variable Modeling to Delineate Psychiatric and Cognitive Profiles in Parkinson Disease. The American Journal of Geriatric Psychiatry, 17(11), 986-995. https://doi.org/10.1097/jgp.0b013e3181b215ec
Mazancova, A. F., Růžička, E., Jech, R., & Bezdicek, O. (2020). Test the Best: Classification Accuracies of Four Cognitive Rating Scales for Parkinson’s Disease Mild Cognitive Impairment. Archives of Clinical Neuropsychology, 35(7), 1069-1077. https://doi.org/10.1093/arclin/acaa039
Meireles, J., & Massano, J. (2012). Cognitive impairment and dementia in Parkinson’s disease: clinical features, diagnosis, and management. Frontiers in neurology, 3, 88.
Milner, B. (1963). Effects of different brain lesions on card sorting: The role of the frontal lobes. Archives of Neurology, 9(1), 90-100.
Milner, B., & Petrides, M. (1984, 1984/11/01/). Behavioural effects of frontal-lobe lesions in man. Trends in Neurosciences, 7(11), 403-407. https://doi.org/https://doi.org/10.1016/S0166-2236(84)80143-5
Mosimann, U. P., Mather, G., Wesnes, K., O’brien, J., Burn, D., & McKeith, I. (2004). Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology, 63(11), 2091-2096.
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239-1245. https://doi.org/10.1212/01.wnl.0000180516.69442.95
Mystakidou, K., Tsilika, E., Parpa, E., Galanos, A., & Vlahos, L. (2007). Brief cognitive assessment of cancer patients: evaluation of the Mini-Mental State Examination (MMSE) psychometric properties. Psycho-Oncology, 16(4), 352-357. https://doi.org/10.1002/pon.1090
Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005, Apr). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4), 695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Nelson, H. E. (1976). A modified card sorting test sensitive to frontal lobe defects. Cortex, 12(4), 313-324.
O’Driscoll, C., & Shaikh, M. (2017). Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review. Journal of Alzheimer's Disease, 58, 789-801. https://doi.org/10.3233/JAD-161042
Ostrosky-Solis, F., Canseco, E., Quintanar, L., And, E. N., Meneses, S., & Ardila, A. (1985, 1985/01/01). Sociocultural Effects in Neuropsychological Assessment. International Journal of Neuroscience, 27(1-2), 53-66. https://doi.org/10.3109/00207458509149134
Owen, A. M., Beksinska, M., James, M., Leigh, P., Summers, B., Marsden, C., Quinn, N., Sahakian, B., & Robbins, T. (1993). Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia, 31(7), 627-644.
Ozdilek, B., & Kenangil, G. (2014). Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in Patients With Parkinson’s Disease. The Clinical Neuropsychologist, 28(2), 333-343. https://doi.org/10.1080/13854046.2014.881554
Pendlebury, S. T., Cuthbertson, F. C., Welch, S. J. V., Mehta, Z., & Rothwell, P. M. (2010). Underestimation of Cognitive Impairment by Mini-Mental State Examination Versus the Montreal Cognitive Assessment in Patients With Transient Ischemic Attack and Stroke. Stroke, 41(6), 1290-1293. https://doi.org/doi:10.1161/STROKEAHA.110.579888
Pendlebury, S. T., Welch, S. J., Cuthbertson, F. C., Mariz, J., Mehta, Z., & Rothwell, P. M. (2013, Jan). Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery. Stroke, 44(1), 227-229. https://doi.org/10.1161/STROKEAHA.112.673384
Peralta, C., Stampfer-Kountchev, M., Karner, E., Köllensperger, M., Geser, F., Wolf, E., Seppi, K., Benke, T., Poewe, W., & Wenning, G. K. (2007). Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. Journal of Neural Transmission, 114(5), 585-588. https://doi.org/10.1007/s00702-006-0615-2
Perepezko, K., Hinkle, J. T., Shepard, M. D., Fischer, N., Broen, M. P. G., Leentjens, A. F. G., Gallo, J. J., & Pontone, G. M. (2019). Social role functioning in Parkinson's disease: A mixed-methods systematic review. International Journal of Geriatric Psychiatry, 34(8), 1128-1138. https://doi.org/10.1002/gps.5137
Perl, D. P., Warren, C. O., & Calne, D. (1998). Alzheimer's disease and parkinson's disease: Distinct entities or extremes of a spectrum of neurodegeneration? Annals of Neurology, 44(S1), S19-S31. https://doi.org/10.1002/ana.410440705
Pigott, K., Rick, J., Xie, S. X., Hurtig, H., Chen-Plotkin, A., Duda, J. E., Morley, J. F., Chahine, L. M., Dahodwala, N., Akhtar, R. S., Siderowf, A., Trojanowski, J. Q., & Weintraub, D. (2015). Longitudinal study of normal cognition in Parkinson disease. Neurology, 85(15), 1276-1282. https://doi.org/10.1212/wnl.0000000000002001
Pinto, T. C., Machado, L., Bulgacov, T. M., Rodrigues-Júnior, A. L., Costa, M. L., Ximenes, R. C., & Sougey, E. B. (2019). Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly. Int Psychogeriatr, 31(4), 491-504.
Pirogovsky, E., Schiehser, D. M., Obtera, K. M., Burke, M. M., Lessig, S. L., Song, D. D., Litvan, I., & Filoteo, J. V. (2014). Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment. Neuropsychology, 28(2), 229.
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. (2014). The prevalence of Parkinson's disease: a systematic review and meta‐analysis. Movement Disorders, 29(13), 1583-1590.
Reitan, R. (1958). Validity of the Trial Making Test as an Indication of Organic Brain Damage, in “Perceptual and Motor Skills”, 8.
Roalf, D. R., Moore, T. M., Wolk, D. A., Arnold, S. E., Mechanic-Hamilton, D., Rick, J., Kabadi, S., Ruparel, K., Chen-Plotkin, A. S., Chahine, L. M., Dahodwala, N. A., Duda, J. E., Weintraub, D. A., & Moberg, P. J. (2016). Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology, Neurosurgery & Psychiatry, 87(12), 1303-1310. https://doi.org/10.1136/jnnp-2015-312723
Robben, S. H. M., Sleegers, M. J. M., Dautzenberg, P. L. J., Van Bergen, F. S., Ter Bruggen, J.-P., & Rikkert, M. G. M. O. (2010). Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose. International Journal of Geriatric Psychiatry, 25(3), 258-265. https://doi.org/10.1002/gps.2331
Sabbagh, M. N., Adler, C. H., Lahti, T. J., Connor, D. J., Vedders, L., Peterson, L. K., Caviness, J. N., Shill, H. A., Sue, L. I., Ziabreva, I., Perry, E., Ballard, C. G., Aarsland, D., Walker, D. G., & Beach, T. G. (2009). Parkinson Disease With Dementia. Alzheimer Disease & Associated Disorders, 23(3), 295-297. https://doi.org/10.1097/wad.0b013e31819c5ef4
Sagar, H. J., Cohen, N. J., Sullivan, E. V., Corkin, S., & Growdon, J. H. (1988). Remote Memory Function in Alzheimer's Disease and Parkinson's Disease. Brain, 111(1), 185-206. https://doi.org/10.1093/brain/111.1.185
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017, 2017/07/01). Non-motor features of Parkinson disease. Nature Reviews Neuroscience, 18(7), 435-450. https://doi.org/10.1038/nrn.2017.62
Schultz-Larsen, K., Kreiner, S., & Lomholt, R. K. (2007, 2007/03/01/). Mini-Mental Status Examination: Mixed Rasch model item analysis derived two different cognitive dimensions of the MMSE. Journal of Clinical Epidemiology, 60(3), 268-279. https://doi.org/https://doi.org/10.1016/j.jclinepi.2006.06.007
Siderowf, A., Xie, S. X., Hurtig, H., Weintraub, D., Duda, J., Chen-Plotkin, A., Shaw, L. M., Van Deerlin, V., Trojanowski, J. Q., & Clark, C. (2010). CSF amyloid 1-42 predicts cognitive decline in Parkinson disease. Neurology, 75(12), 1055-1061. https://doi.org/10.1212/wnl.0b013e3181f39a78
Skorvanek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorova, I., Schmand, B., Van Duijn, E., Goetz, C. G., Weintraub, D., Stebbins, G. T., & Martinez-Martin, P. (2018). Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Movement Disorders, 33(2), 208-218. https://doi.org/10.1002/mds.27233
Smith, C., Malek, N., Grosset, K., Cullen, B., Gentleman, S., & Grosset, D. G. (2019). Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies. Journal of Neurology, Neurosurgery &amp; Psychiatry, 90(11), 1234-1243. https://doi.org/10.1136/jnnp-2019-321111
Smith, G. E., Ivnik, R. J., Malec, J. F., Kokmen, E., Tangalos, E., & Petersen, R. C. (1994). Psychometric properties of the mattis dementia rating scale. Assessment, 1(2), 123-131.
Sommerlad, A., Singleton, D., Jones, R., Banerjee, S., & Livingston, G. (2017). Development of an instrument to assess social functioning in dementia: The Social Functioning in Dementia scale (SF‐DEM). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 7(1), 88-98. https://doi.org/10.1016/j.dadm.2017.02.001
Starkstein, S. E., Mayberg, H. S., Preziosi, T., Andrezejewski, P., Leiguarda, R., & Robinson, R. (1992). Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci, 4(2), 134-139.
Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of experimental psychology, 18(6), 643.
Su, F. T., Tai, C.-H., Tan, C.-H., Hwang, W.-J., & Yu, R.-L. (2020). The Development of the Social Functioning Scale for Patients with Parkinson’s Disease. Journal of Parkinson's Disease, 10, 1143-1151. https://doi.org/10.3233/JPD-201930
Sulzer, P., Becker, S., Maetzler, W., Kalbe, E., van Nueten, L., Timmers, M., Machetanz, G., Streffer, J., Salvadore, G., Scholz, E., Tkaczynska, Z., Brockmann, K., Berg, D., & Liepelt-Scarfone, I. (2018, 2018/09/01). Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson’s disease patients. Journal of Neurology, 265(9), 1976-1984. https://doi.org/10.1007/s00415-018-8942-4
Sunderland, T., Hill, J. L., Mellow, A. M., Lawlor, B. A., Gundersheimer, J., Newhouse, P. A., & Grafman, J. H. (1989). Clock drawing in Alzheimer's disease: a novel measure of dementia severity. Journal of the American Geriatrics Society, 37(8), 725-729.
Tansey, M. G., & Goldberg, M. S. (2010). Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiology of disease, 37(3), 510-518.
Taylor, A. E., Saint-Cyr, J. A., & Lang, A. E. (1986). Frontal Lobe Dysfunction in Parkinson's Disease. Brain, 109(5), 845-883. https://doi.org/10.1093/brain/109.5.845
Toglia, J., Fitzgerald, K. A., O'Dell, M. W., Mastrogiovanni, A. R., & Lin, C. D. (2011). The Mini-Mental State Examination and Montreal Cognitive Assessment in Persons With Mild Subacute Stroke: Relationship to Functional Outcome. Archives of Physical Medicine and Rehabilitation, 92(5), 792-798. https://doi.org/10.1016/j.apmr.2010.12.034
Tsai, C. F., Lee, W. J., Wang, S. J., Shia, B. C., Nasreddine, Z., & Fuh, J. L. (2012, Apr). Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr, 24(4), 651-658. https://doi.org/10.1017/S1041610211002298
Tyrer, P. E., & Casey, P. E. (1993). Social function in psychiatry: The hidden axis of classification exposed. Wrightson Biomedical Publishing.
Uysal-Cantürk, P., Hanağası, H. A., Bilgiç, B., Gürvit, H., & Emre, M. (2018). An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease. European Journal of Neurology, 25(1), 148-153. https://doi.org/10.1111/ene.13467
Visser, M., Leentjens, A. F., Marinus, J., Stiggelbout, A. M., & van Hilten, J. J. (2006). Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society, 21(5), 668-672.
von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., Poewe, W., Oertel, W., Siebert, U., Berger, K., & Dodel, R. (2005). Prevalence and incidence of Parkinson's disease in Europe. European Neuropsychopharmacology, 15(4), 473-490.
Wallace, E. R., Segerstrom, S. C., van Horne, C. G., Schmitt, F. A., & Koehl, L. M. (2021, 2021/04/16). Meta-Analysis of Cognition in Parkinson’s Disease Mild Cognitive Impairment and Dementia Progression. Neuropsychology Review. https://doi.org/10.1007/s11065-021-09502-7
Wang, C. S.-M., Pai, M.-C., Chen, P.-L., Hou, N.-T., Chien, P.-F., & Huang, Y.-C. (2013). Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan. International Psychogeriatrics, 25(11), 1839-1848. https://doi.org/10.1017/S1041610213001245
Warrington, E. K., & James, M. (1991). The visual object and space perception battery.
Wechsler, D. (1997). Wechsler memory scale (WMS-III) (Vol. 14). Psychological corporation San Antonio, TX.
Weintraub, D., Dietz, N., Duda, J. E., Wolk, D. A., Doshi, J., Xie, S. X., Davatzikos, C., Clark, C. M., & Siderowf, A. (2012). Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain, 135(1), 170-180. https://doi.org/10.1093/brain/awr277
Weintraub, D., Oehlberg, K. A., Katz, I. R., & Stern, M. B. (2006). Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. The American Journal of Geriatric Psychiatry, 14(2), 169-175.
Weissman, M. M. (1975). The Assessment of Social Adjustment: A Review of Techniques. Archives of General Psychiatry, 32(3), 357-365. https://doi.org/10.1001/archpsyc.1975.01760210091006
Weissman, M. M., & Bothwell, S. (1976). Assessment of Social Adjustment by Patient Self-Report. Archives of General Psychiatry, 33(9), 1111-1115. https://doi.org/10.1001/archpsyc.1976.01770090101010
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002). Nonmotor fluctuations in Parkinson’s disease. Frequent and disabling, 59(3), 408-413. https://doi.org/10.1212/wnl.59.3.408
Wittich, W., Phillips, N., Nasreddine, Z. S., & Chertkow, H. (2010). Sensitivity and Specificity of the Montreal Cognitive Assessment Modified for Individuals who are Visually Impaired. Journal of Visual Impairment & Blindness, 104(6), 360-368. https://doi.org/10.1177/0145482x1010400606
Wooten, G., Currie, L., Bovbjerg, V., Lee, J., & Patrie, J. (2004). Are men at greater risk for Parkinson’s disease than women? Journal of Neurology, Neurosurgery & Psychiatry, 75(4), 637-639.
Xu, S. L., G; Zhu, IH; Li, YG. (2015). The research of using Montreal cognitive assessment to evaluate mild cognitive impairment in patients with Parkinson's disease. Chinese Journal ofRehabilitation Medicine, 3.
Xu, X., Chan, Q. L., Hilal, S., Ikram, M. K., Venketasubramanian, N., Tan, B. Y., Dong, Y., Chen, C. L.-H., & Collinson, S. L. (2016). The Diagnostic Utility of the NINDS-CSN Neuropsychological Battery in Memory Clinics. Dementia and Geriatric Cognitive Disorders Extra, 6(2), 276-282. https://doi.org/10.1159/000445050
Yu, R. L., Wu, R.-M., Chan, A. Y. Y., Mok, V., Wu, Y.-R., Tilley, B. C., Luo, S., Wang, L., Lapelle, N. R., Stebbins, G. T., & Goetz, C. G. (2017). Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Movement Disorders Clinical Practice, 4(1), 68-77. https://doi.org/10.1002/mdc3.12349
Yu, R. L., Wu, R.-M., Tai, C.-H., Lin, C.-H., Cheng, T.-W., & Hua, M.-S. (2012, 2012/12/01/). Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan. Parkinsonism & Related Disorders, 18(10), 1067-1072. https://doi.org/https://doi.org/10.1016/j.parkreldis.2012.06.002
Yu, R. L., Lee, W. J., Li, J. Y., Chang, Y. Y., Chen, C. C., Lin, J. J., Sung, Y. F., Lin, T. K., & Fuh, J. L. (2020, Jan 23). Evaluating Mild Cognitive Dysfunction in Patients with Parkinson's Disease in Clinical Practice in Taiwan. Sci Rep, 10(1), 1014.https://doi.org/10.1038/s41598-020-58042-2